Christopher Daugherty

Christopher Daugherty is a Professor in the Department of Medicine-Hematology and Oncology at the University of Chicago. His research focuses on ethical issues in cancer care, particularly related to clinical trials, informed consent, and decision-making for patients with advanced cancer.

Dr. Daugherty's research interests span several critical areas in oncology and medical ethics:

• Ethical considerations in phase I clinical trials for advanced cancer patients
• Patient understanding of prognosis and informed consent
• Financial toxicity in cancer care
• Integration of palliative care in oncology
• Medication shortages and resource allocation in cancer care
• Psychosocial aspects of cancer survivorship
• Genetic counseling and BRCA testing

His publication record demonstrates consistent contributions to the field of oncology ethics since the mid-1990s, with a particular emphasis on understanding patient perspectives in clinical research. Recent work has expanded to address contemporary challenges including the impact of the COVID-19 pandemic on oncology practice, electronic patient-reported outcomes, and the ethical dimensions of medication shortages.

Dr. Daugherty served as Principal Investigator for the NIH-funded research project "Ethics and Clinical Trials in Advanced Cancer Care" (R01CA087605) from 2000 to 2012, demonstrating sustained research support in his area of expertise.

His collaborative work extends across multiple institutions and disciplines, reflecting the interdisciplinary nature of medical ethics research in oncology. He has mentored numerous researchers in the field, as evidenced by his extensive publication record with various co-authors across different career stages.